The mechanism and function of the potential IL-17RC-only transduction of IL-17 signaling remains to be explored and may provide further insight into the development of therapeutic agents for autoimmune diseases, such as psoriasis, where a blockade of IL-17A and IL-17RA showed significant efficacy. This evidence concerns the gene IL17A and psoriasis.